Recent Faculty Publications

Stone GW. DAPT Duration After Coronary Stenting: Assessing Risk-Benefit Tradeoffs in Individual Patients. J Am Coll Cardiol. 2016 May 31;67(21):2503-5.

Bersano A, Markus HS, Quaglini S, Arbustini E, Lanfranconi S, Micieli G, Boncoraglio GB, Taroni F, Gellera C, Baratta S, Penco S, Mosca L, Grasso M, Carrera P, Ferrari M, Cereda C, Grieco G, Corti S, Ronchi D, Teresa Bassi M, Obici L, Parati EA, Pezzini A, De Lodovici ML, Verrengia EP, Bono G, Mazucchelli F, Zarcone D, Calloni MV, Perrone P, Bordo BM, Colombo A, Padovani A, Cavallini A, Beretta S, Ferrarese C, Motto C, Agostoni E, Molini G, Sasanelli F, Corato M, Marcheselli S, Sessa M, Comi G, Checcarelli N, Guidotti M, Uccellini D, Capitani E, Tancredi L, Arnaboldi M, Incorvaia B, Tadeo CS, Fusi L, Grampa G, Merlini G, Trobia N, Comi GP, Braga M, Vitali P, Baron P, Grond-Ginsbach C, Candelise L. Clinical Pregenetic Screening for Stroke Monogenic Diseases: Results From Lombardia GENS Registry. Stroke. 2016 May 31.

Chin CY, Maehara A, Fall K, Mintz GS, Ali ZA. Imaging Comparisons of Coregistered Native and Stented Coronary Segments by High-Definition 60-MHz Intravascular Ultrasound and Optical Coherence Tomography. JACC Cardiovasc Interv. 2016 May 27. pii: S1936-8798(16)30424-1.

Jahangiri M, Bilkhu R, Borger M, Falk V, Helleman I, Leigh B, Mack M, Quintana E, Sousa Uva M, Westaby S, Pomar JL. The value of surgeon-specific outcome data: results of a questionnaire. Eur J Cardiothorac Surg. 2016 May 26.

Abdelghani M, Tateishi H, Spitzer E, Tijssen JG, de Winter RJ, Soliman OI, Hahn RT, Serruys PW. Echocardiographic and angiographic assessment of paravalvular regurgitation after TAVI: optimizing inter-technique reproducibility. Eur Heart J Cardiovasc Imaging. 2016 May 25.

Head SJ, Mylotte D, Mack MJ, Piazza N, van Mieghem NM, Leon MB, Kappetein AP, Holmes DR Jr. Considerations and Recommendations for the Introduction of Objective Performance Criteria for Transcatheter Aortic Heart Valve Device Approval.Circulation. 2016 May 24;133(21):2086-93.

Tanaka A, Jabbour RJ, Kawamoto H, Mangieri A, Pagnesi M, Montalto C, Chieffo A, Carlino M, Montorfano M, Latib A, Colombo A.Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation. Catheter Cardiovasc Interv. 2016 May 24.

Kawamoto H, Ruparelia N, Tanaka A, Chieffo A, Latib A, Colombo A. Bioresorbable Scaffolds for the Management of Coronary Bifurcation Lesions. JACC Cardiovasc Interv. 2016 May 23;9(10):989-1000.

Rafique AM, Nayyar P, Wang TY, Mehran R, Baber U, Berger PB, Tobis J, Currier J, Dave RH, Henry TD. Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis. JACC Cardiovasc Interv. 2016 May 23;9(10):1036-46.

Sorabella RA, Guglielmetti L, Bader A, Gomez A, Takeda K, Chai PJ, Takayama H, Bacha EA, Naka Y, George I. The Use of Hypothermic Circulatory Arrest During Heart Transplantation Does Not Worsen Posttransplant Survival. Ann Thorac Surg. 2016 May 18.

Généreux P, Stone GW, O'Gara PT, Marquis-Gravel G, Redfors B, Giustino G, Pibarot P, Bax JJ, Bonow RO, Leon MB. Natural History, Diagnostic Approaches, and Therapeutic Strategies for Patients With Asymptomatic Severe Aortic Stenosis. J Am Coll Cardiol. 2016 May 17;67(19):2263-88.

Baber U, Mehran R, Giustino G, Cohen DJ, Henry TD, Sartori S, Ariti C, Litherland C, Dangas G, Gibson CM, Krucoff MW, Moliterno DJ, Kirtane AJ, Stone GW, Colombo A, Chieffo A, Kini AS, Witzenbichler B, Weisz G, Steg PG, Pocock S. Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. J Am Coll Cardiol. 2016 May 17;67(19):2224-34.

Xu B, Gao R, Yang Y, Cao X, Qin L, Li Y, Li Z, Li X, Lin H, Guo Y, Ma Y, Wang J, Nie S, Xu L, Cao E, Guan C, Stone GW; PANDA III Investigators. Biodegradable Polymer-Based Sirolimus-Eluting Stents With Differing Elution and Absorption Kinetics: The PANDA III Trial. J Am Coll Cardiol. 2016 May 17;67(19):2249-58.

Theodoropoulos K, Mennuni MG, Dangas GD, Meelu OA, Bansilal S, Baber U, Sartori S, Kovacic JC, Moreno PR, Sharma SK, Mehran R, Kini AS. Resistant in-stent restenosis in the drug eluting stent era. Catheter Cardiovasc Interv. 2016 May 17.

Karatasakis A, Tarar MN, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Wyman RM, Lombardi WL, Grantham JA, Kandzari DE, Lembo NJ, Moses JW, Kirtane AJ, Parikh M, Garcia S, Doing A, Pershad A, Shah A, Patel M, Bahadorani J, Shoultz CA Jr, Danek BA, Thompson CA, Banerjee S, Brilakis ES. Guidewire and microcatheter utilization patterns during antegrade wire escalation in chronic total occlusion percutaneous coronary intervention: Insights from a contemporary multicenter registry. Catheter Cardiovasc Interv. 2016 May 17.

Tanaka A, Latib A, Kawamoto H, Jabbour RJ, Mangieri A, Pagnesi M, Montalto C, Regazzoli D, Ancona M, Chieffo A, Carlino M, Montorfano M, Colombo A. Clinical outcomes following bifurcation double-stenting with bioresorbable scaffolds. Catheter Cardiovasc Interv. 2016 May 17.

Ruparelia N, Mangieri A, Ancona M, Giannini F, Agricola E, Montorfano M, De Bonis M, Alfieri O, Colombo A, Latib A. Percutaneous Transcatheter Treatment for Tricuspid Bioprosthesis Failure. Catheter Cardiovasc Interv. 2016 May 17.

Haude M, Ince H, Abizaid A, Toelg R, Lemos PA, von Birgelen C, Christiansen EH, Wijns W, Neumann FJ, Kaiser C, Eeckhout E, Lim ST, Escaned J, Onuma Y, Garcia-Garcia HM, Waksman R. Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial. Eur Heart J. 2016 May 17.

Naber CK, Urban P, Ong PJ, Valdes-Chavarri M, Abizaid AA, Pocock SJ, Fabbiocchi F, Dubois C, Copt S, Greene S, Morice MC; LEADERS FREE Investigators. Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study. Eur Heart J. 2016 May 17.

Peña JM, Min JK. Coronary artery disease: Sex-related differences in CAD and plaque characteristics. Nat Rev Cardiol. 2016 May 16;13(6):318-9.

D'Ascenzo F, Iannaccone M, Giordana F, Chieffo A, Connor SO, Napp LC, Chandran S, de la Torre Hernández JM, Chen SL, Varbella F, Omedè P, Taha S, Meliga E, Kawamoto H, Montefusco A, Chong M, Garot P, Sin L, Gasparetto V, Abdirashid M, Cerrato E, Biondi-Zoccai G, Gaita F, Escaned J, Hiddick Smith D, Lefèvre T, Colombo A, Sheiban I, Moretti C. Provisional vs. two-stent technique for unprotected left main coronary artery disease after ten years follow up: A propensity matched analysis. Int J Cardiol. 2016 May 15;211:37-42.

McCabe JM, Huang PH, Cohen DJ, Blackstone EH, Welt FG, Davidson MJ, Kaneko T, Eng MH, Allen KB, Xu K, Lowry AM, Lei Y, Rajeswaran J, Brown DL, Mack MJ, Webb JG, Smith CR, Leon MB, Eisenhauer AC; PARTNER Trial Investigators. Surgical Versus Percutaneous Femoral Access for Delivery of Large-Bore Cardiovascular Devices (from the PARTNER Trial). Am J Cardiol. 2016 May 15;117(10):1643-50.

Slavich M, Maranta F, Fumero A, Godino C, Giannini F, Oppizzi M, Colombo A, Fragasso G, Margonato A. Long-Term Preservation of Left Ventricular Systolic Function in Patients With Refractory Angina Pectoris and Inducible Myocardial Ischemia on Optimal Medical Therapy. Am J Cardiol. 2016 May 15;117(10):1558-61.

Van Belle E, Hengstenberg C, Lefevre T, Kupatt C, Debry N, Husser O, Pontana F, Kuchcinski G, Deliargyris EN, Mehran R, Bernstein D, Anthopoulos P, Dangas GD; BRAVO-3 MRI Study Investigators. Cerebral Embolization During Transcatheter Aortic Valve Replacement: The BRAVO-3 MRI Study. J Am Coll Cardiol. 2016 May 13

Mehran R, Giustino G. "Capturing" the Benefits of Dual-Therapy Stent Technology: Is This a Promise or Reality? JACC Cardiovasc Interv. 2016 May 13.

Pérez-Medina C, Binderup T, Lobatto ME, Tang J, Calcagno C, Giesen L, Wessel CH, Witjes J, Ishino S, Baxter S, Zhao Y, Ramachandran S, Eldib M, Sánchez-Gaytán BL, Robson PM, Bini J, Granada JF, Fish KM, Stroes ES, Duivenvoorden R, Tsimikas S, Lewis JS, Reiner T, Fuster V, Kjær A, Fisher EA, Fayad ZA, Mulder WJ. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models. JACC Cardiovasc Imaging. 2016 May 13.

Latib A, Ancona MB, Agricola E, Giannini F, Mangieri A, Regazzoli D, Monaco F, Alfieri O, Hahn R, Colombo A. Percutaneous Bicuspidization of the Tricuspid Valve. JACC Cardiovasc Imaging. 2016 May 12.

Ben-Yehuda O, Redfors B. Validation of the Bleeding Academic Research Consortium Bleeding Definition: Towards a Standardized Bleeding Score. J Am Coll Cardiol. 2016 May 10;67(18):2145-7.

Spartera M, Schiavo Lena M, Sanvito F, Colombo A. Early degeneration and endocarditis in a trans-catheter heart valve. Eur Heart J. 2016 May 8.

Nietlispach F, Maisano F, Sorajja P, Leon MB, Rihal C, Feldman T. Percutaneous paravalvular leak closure: chasing the chameleon.Eur Heart J. 2016 May 8.

Chandrasekhar J, Baber U, Sartori S, Faggioni M, Aquino M, Kini A, Weintraub W, Rao S, Kapadia S, Weiss S, Strauss C, Toma C, Muhlestein B, DeFranco A, Effron M, Keller S, Baker B, Pocock S, Henry T, Mehran R. Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS Study. Catheter Cardiovasc Interv. 2016 May 6.

Kang SJ, Kweon J, Yang DH, Lee JG, Jung J, Kim N, Mintz GS, Kang JW, Lim TH, Park SW, Kim YH. Mathematically Derived Criteria for Detecting Functionally Significant Stenoses Using Coronary Computed Tomographic Angiography-Based Myocardial Segmentation and Intravascular Ultrasound-Measured Minimal Lumen Area. Am J Cardiol. 2016 May 5.

Fortunato de Cano S, Nicolas Cano M, de Ribamar Costa J Jr, Alves Pinheiro J Jr, Bellio de Mattos Barretto R, Costa de Souza Le Bihan D, Abizaid A, Sousa A, Eduardo Sousa J. Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy. Catheter Cardiovasc Interv. 2016 May 3.

Diletti R, Tchetche D, Barbato E, Latib A, Farah B, van Geuns RJ, Colombo A, Fajadet J, van Mieghem NM. Bioresorbable scaffolds for treatment of coronary bifurcation lesions: Critical appraisal and future perspectives. Catheter Cardiovasc Interv. 2016 May 3.

Danad I, Szymonifka J, Twisk JW, Norgaard BL, Zarins CK, Knaapen P, Min JK. Diagnostic performance of cardiac imaging methods to diagnose ischaemia-causing coronary artery disease when directly compared with fractional flow reserve as a reference standard: a meta-analysis. Eur Heart J. 2016 May 2.

Carlino M, Ruparelia N, Thomas G, Brooks M, Uretsky BF, Brilakis ES, Karmpaliotis D, Hanratty C, Walsh S, Spratt J, Colombo A.Modified contrast microinjection technique to facilitate chronic total occlusion recanalization. Catheter Cardiovasc Interv. 2016 May;87(6):1036-41.

Endorsed by the Latin American Society of Interventional Cardiology; PCI WRITING COMMITTEE, Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH; STEMI WRITING COMMITTEE, O'Gara PT, Kushner FG, Ascheim DD, Brindis RG, Casey DE Jr, Chung MK, de Lemos JA, Diercks DB, Fang JC, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Kristin Newby L, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Joseph Woo Y, Zhao DX; ACC/AHA TASK FORCE MEMBERS, Halperin JL, Levine GN, Anderson JL, Albert NM, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, Cigarroa JE, Curtis LH, Fleisher LA, Gentile F, Gidding S, Hlatky MA, Ikonomidis J, Joglar J, Kovacs RJ, Magnus Ohman E, Pressler SJ, Sellke FW, Shen WK, Wijeysundera DN. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2016 May;87(6):1001-19.

Kamperidis V, Delgado V, van Mieghem NM, Kappetein AP, Leon MB, Bax JJ. Diagnosis and management of aortic valve stenosis in patients with heart failure. Eur J Heart Fail. 2016 May;18(5):469-81.

Leontyev S, Légaré JF, Borger MA, Buth KJ, Funkat AK, Gerhard J, Mohr FW. Creation of a Scorecard to Predict In-Hospital Death in Patients Undergoing Operations for Acute Type A Aortic Dissection. Ann Thorac Surg. 2016 May;101(5):1700-6

Redfors B, Généreux P. Ranolazine following percutaneous coronary intervention: For whom? For what? Expert Rev Cardiovasc Ther. 2016 May;14(5):541-3.

Shavelle DM, Kirtane AJ, Schreiber TL, Kapasi NK, O'Neill WW, Moses JW, Popma J, Matthews RV. Impact of Surgical Consultation on Outcomes in Hemodynamically Supported High-Risk Percutaneous Coronary Intervention: Insights From PROTECT II Randomized Study. J Invasive Cardiol. 2016 May;28(5):187-92.

Budoff MJ, Nakazato R, Mancini GB, Gransar H, Leipsic J, Berman DS, Min JK. CT Angiography for the Prediction of Hemodynamic Significance in Intermediate and Severe Lesions: Head-to-Head Comparison With Quantitative Coronary Angiography Using Fractional Flow Reserve as the Reference Standard. JACC Cardiovasc Imaging. 2016 May;9(5):559-64.

Kanwar SS, Stone GW, Singh M, Virmani R, Olin J, Akasaka T, Narula J. Acute coronary syndromes without coronary plaque rupture.Nat Rev Cardiol. 2016 May;13(5):257-65.

Jabbour RJ, Pagnesi M, Kawamoto H, Tanaka A, Regazzoli D, Mangieri A, Ancona M, Monaco F, Agricola E, Spagnolo P, Castiglioni A, De Angelis G, Chieffo A, Montorfano M, Colombo A, Latib A. Transcatheter aortic valve implantation in intermediate- and low-risk populations: An inevitable progression? Int J Cardiol. 2016 May 1;210:35-7.

Gottlieb S, Kolker S, Shlomo N, Matetzky S, Leitersdorf E, Segev A, Goldenberg I, Tzivoni D, Weisz G, Moriel M. Association between statin treatment and LDL-cholesterol levels on the rate of ST-elevation myocardial infarction among patients with acute coronary syndromes: ACS Israeli Survey (ACSIS) 2002-2010. Int J Cardiol. 2016 May 1;210:133-8.

Smilowitz NR, Pirmohamed A, Weisz G. Published Articles Reporting Studies by Industry Employees on Interventional Cardiology Devices: Scope and Association With Study Outcomes. JAMA Intern Med. 2016 May 1;176(5):706-8.

Ruparelia N, Latib A, Kawamoto H, Buzzatti N, Giannini F, Figini F, Mangieri A, Regazzoli D, Stella S, Sticchi A, Tanaka A, Ancona M, Agricola E, Monaco F, Spagnolo P, Chieffo A, Montorfano M, Alfieri O, Colombo A. A Comparison Between First-Generation and Second-Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Propensity-Matched Single-Center Experience. J Invasive Cardiol. 2016 May;28(5):210-6.

Hari P, Kirtane AJ, Bangalore S. Retrograde approach to an ostial left anterior descending chronic total occlusion through a left internal mammary artery graft. Catheter Cardiovasc Interv. 2016 May;87(6):E224-E228.

Dangas GD, Schoos MM, Steg PG, Mehran R, Clemmensen P, van 't Hof A, Prats J, Bernstein D, Deliargyris EN, Stone GW. Early Stent Thrombosis and Mortality After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Patient-Level Analysis of 2 Randomized Trials. Circ Cardiovasc Interv. 2016 May;9(5):e003272.